新型コロナウイルスワクチンの特例承認について｜厚生労働省
https://www.mhlw.go.jp/stf/newpage_23486.html新型コロナウイルスワクチンの特例承認について｜厚生労働省
Open the dedicated viewer to inspect the saved page with archive metadata pinned above it, similar to archive wrappers such as Web Gyotaku.
This is a self-contained HTML copy with CSS and images embedded, so it still renders even if the original page disappears.
The dedicated viewer keeps the original URL and saved timestamp visible while you review the archived HTML.
This page presents a press release from the Ministry of Health, Labour and Welfare dated January 21, 2022, regarding the special approval of a COVID-19 vaccine. Pfizer's "Comirnaty Intramuscular Injection for Ages 5-11" received special approval under pharmaceutical law. The vaccine is intended to prevent SARS-CoV-2 infection. The administration method involves diluting the vaccine in saline solution and administering two intramuscular injections with a three-week interval between doses.
